Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Intrachromosomal amplification of chromosome 21 (iAMP21) is known to be associated with poor prognosis in B-cell ALL (B-ALL). To determine the frequency and clinical characteristics of iAMP21 in Korean B-ALL patients, we performed FISH and multiplex ligation-dependent probe amplification (MLPA) analyses. Methods: A total of 102 childhood B-ALL patients were screened with ETV6-RUNX1 FISH probes (Abbott Molecular, USA). The presence of an iAMP21 was confirmed by using MLPA P327 iAMP21-ERG probemix (MRC Holland, The Netherlands). Results: iAMP21 was detected in one of the screened B-ALL patients (1/102 patients, 1.0%) who presented the ALL immunophenotype and complex karyotype at initial diagnosis. The patient relapsed twice after bone marrow transplantation. MLPA showed 12.5-Mb and 4.28-Mb regions of amplification and deletion, respectively. Conclusions: The frequency of iAMP21 is considerable in Korean pediatric patients. Our report suggests that iAMP21 in childhood B-ALL has very unfavorable impact on patient’s prognosis. Additional methods such as MLPA analysis is essential to rule out patients with equivocal interphase FISH results.
Abstract
Background: Intrachromosomal amplification of chromosome 21 (iAMP21) is known to be associated with poor prognosis in B-cell ALL (B-ALL). To determine the frequency and clinical characteristics of iAMP21 in Korean B-ALL patients, we performed FISH and multiplex ligation-dependent probe amplification (MLPA) analyses. Methods: A total of 102 childhood B-ALL patients were screened with ETV6-RUNX1 FISH probes (Abbott Molecular, USA). The presence of an iAMP21 was confirmed by using MLPA P327 iAMP21-ERG probemix (MRC Holland, The Netherlands). Results: iAMP21 was detected in one of the screened B-ALL patients (1/102 patients, 1.0%) who presented the ALL immunophenotype and complex karyotype at initial diagnosis. The patient relapsed twice after bone marrow transplantation. MLPA showed 12.5-Mb and 4.28-Mb regions of amplification and deletion, respectively. Conclusions: The frequency of iAMP21 is considerable in Korean pediatric patients. Our report suggests that iAMP21 in childhood B-ALL has very unfavorable impact on patient’s prognosis. Additional methods such as MLPA analysis is essential to rule out patients with equivocal interphase FISH results.
참고문헌 (14)
- Pui C-H, "Childhood leukemias", pp.880S~ (2012), Cambridge University Press
- Harewood L, "Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases", Leukemia, 17, pp.547~553 (2003)
- Harrison CJ, "Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study", Br J Haematol, 129, pp.520~530 (2005)
- Harrison CJ, "Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group", Br J Haematol, 151, pp.132~142 (2010)
- Reichard KK, "Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases", Mod Pathol, 24, pp.1606~1611 (2011)
- Moorman AV, "Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)", Blood, 109, pp.2327~2330 (2007)
- Harrison CJ, "Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease", Blood, 125, pp.1383~1386 (2015)
- Strefford JC, "Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21", Proc Natl Acad Sci U S A, 103, pp.8167~8172 (2006)
- Harrison CJ, "An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome", Leukemia, 28, pp.1015~1021 (2014)
- Rand V, "Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia", Blood, 117, pp.6848~6855 (2011)
- Robinson HM, "Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle", Genes Chromosomes Cancer, 46, pp.318~326 (2007)
- Harrison CJ, "Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia", Br J Haematol, 144, pp.147~156 (2009)
- Dirse V, "A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients", Genes Chromosomes Cancer, 54, pp.326~333 (2015)
- Schouten JP, "Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification", Nucleic Acids Res, 30, pp.e57~ (2002)